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Abstract 
A coordinated system of disease surveillance will be critical to 
effectively control the coronavirus disease 2019 (Covid-19) pandemic. 
Such systems enable rapid detection and mapping of epidemics and 
inform allocation of scarce prevention and intervention resources. 
Although many lower- and middle-income settings lack infrastructure 
for optimal disease surveillance, health and demographic surveillance 
systems (HDSS) provide a unique opportunity for epidemic 
monitoring. This protocol describes a surveillance program at the 
Africa Health Research Institute’s Population Intervention Platform 
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site in northern KwaZulu-Natal. The program leverages a 
longstanding HDSS in a rural, resource-limited setting with very high 
prevalence of HIV and tuberculosis to perform Covid-19 surveillance. 
Our primary aims include: describing the epidemiology of the Covid-
19 epidemic in rural KwaZulu-Natal; determining the impact of the 
Covid-19 outbreak and non-pharmaceutical control interventions (NPI) 
on behaviour and wellbeing; determining the impact of HIV and 
tuberculosis on Covid-19 susceptibility; and using collected data to 
support the local public-sector health response. 
The program involves telephone-based interviews with over 20,000 
households every four months, plus a sub-study calling 750 
households every two weeks. Each call asks a household 
representative how the epidemic and NPI are affecting the household 
and conducts a Covid-19 risk screen for all resident members. Any 
individuals screening positive are invited to a clinical screen, potential 
test and referral to necessary care – conducted in-person near their 
home following careful risk minimization procedures. In this protocol 
we report the details of our cohort design, questionnaires, data and 
reporting structures, and standard operating procedures in hopes 
that our project can inform similar efforts elsewhere.
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            Amendments from Version 1
This version takes into account comments by the reviewers, 
specifically:
1. How we will determine the impact of Covid-19 outbreak 
and non-pharmaceutical control interventions on individual 
behaviour and wellbeing, household socio-economic status and 
health service delivery.
2.  We provide Additional information on the planned qualitative 
work, methodology, and tools to be used.
3.  We provide information on the phone coverage in the Demo-
graphic Surveillance Area
4.  We provide information on the average time it takes to 
complete the questionnaires
Any further responses from the reviewers can be found at 
the end of the article
REVISED
Introduction
The global emergence of the novel coronavirus, SARS-CoV-2, 
and the associated pandemic of coronavirus disease 2019 
(Covid-19) in humans, has led to substantial morbidity and 
mortality1. Models project continued risk until effective treatment 
or vaccines become available, or sufficient immunity is induced 
in the population to limit transmission2,3. The transmission and 
clinical patterns of the pandemic have been well documented in 
areas of the world where systematic data capture is in place4–7. 
However, data from low- and middle-income countries 
(LMIC) remain scant.
Multiple factors place resource-limited settings at considerable 
risk of epidemics of respiratory disease. Housing structures, 
large informal work sectors, high population density (particularly 
in urban slums and settlements), lack of running water and 
access to hygiene resources, and a health infrastructure unpre-
pared for diseases requiring advanced medical equipment, all 
place LMICs at risk of worse outcomes than higher-income 
settings8–12. There have long been calls for strengthening pub-
lic health preparedness in such countries13,14, but despite some 
progress15, significant capacity shortfalls remain in many 
LMICs16–18. As a result, low case numbers in resource-limited 
settings should not necessarily be interpreted to reflect a lack of 
disease transmission. A coordinated system of disease surveil-
lance will be critical to effective prevention, control, and response 
to the Covid-19 epidemic in LMICs to enable rapid detection, 
transmission mapping, and non-pharmaceutical interventions, and 
to inform allocation of scarce prevention and intervention 
resources.
A unique opportunity for epidemic monitoring within the 
sub-Saharan Africa region is the presence of longstanding health 
and demographic surveillance systems (HDSS)19–21. These rou-
tine data collection systems can serve as a vital tool in the public 
health response to Covid-19. HDSS data are typically collected 
through interviews that generate population-representative 
longitudinal cohorts, including information on demograph-
ics (births, deaths, migration), health status and behaviours. 
Historically, they have been conducted in person, however, 
they have increasingly incorporated telephonic or online data 
collection22,23. Additionally, HDSS are well-positioned to evalu-
ate the long-term impacts of the epidemic, by measuring: 
(i) disease penetration through serologic testing; (ii) causes 
of death during and after the epidemic through the use of ver-
bal autopsies24–26; and epidemic impact on economic indicators, 
and non-Covid healthcare access and health outcomes through 
ongoing interviews.
This protocol paper describes the program developed by the 
Africa Health Research Institute (AHRI) to leverage a long-
standing HDSS to perform Covid-19 surveillance in a rural, 
resource-limited setting with very high prevalence of HIV and 
tuberculosis. In this protocol we illustrate how we have 
leveraged existing expertise and population-based surveillance 
infrastructure to conduct comprehensive Covid-19 surveillance 
in a rural area without existing surveillance capacity for rap-
idly evolving epidemic disease. We also highlight measures 
taken to minimize Covid-19 transmission risk while conducting 
this research. We provide our methods and surveillance tools 
as potential sources of guidance for others working in similar 
settings.
Protocol
Study aim and objectives
The aims of this study are to conduct active Covid-19 surveil-
lance and to estimate the health and non-health impacts of the 
Covid-19 epidemic in rural South Africa. To achieve these 
aims we will implement longitudinal surveillance based on 
regular telephonic contact with households in a geographically 
defined population. This surveillance will allow us to meet the 
following programmatic and scientific objectives:
a. Support the local public health response by the 
Department of Health (DoH) through screening, 
testing, case notification and linking Covid-19 cases to 
care;
b. Describe the incidence and evolution of Covid-19 
epidemic in a well-defined population in rural KwaZulu-
Natal, including its distribution by age, gender 
and socio-demographic characteristics;
c. Determine the impact of the Covid-19 outbreak and 
non-pharmaceutical control interventions on individual 
behaviour and wellbeing, household socio-economic 
status and health service delivery;
d. Determine the impact of pre-existing health conditions, 
including HIV and tuberculosis on Covid-19 
susceptibility, clinical presentation and outcomes.
Study setting
The study will be conducted within the AHRI Population Inter-
vention Platform surveillance area in the uMkhanyakude 
district of KwaZulu-Natal province. The study area covers 
approximately 850 km2; it is largely rural with one town of 
approximately 30,000 residents, and among the lowest-ranked 
areas in South Africa in terms of socioeconomic status27. A 
large proportion of the population live with HIV (~20% of men 
and ~40% of women aged 15–54 in 201728). Tuberculosis inci-
dence in the district in 2015 was above the national average of 
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577 per 100,000 individuals29. Mobile phone ownership in the 
population is high, 90% of households report owning a phone 
and in 84% of households there is a valid phone number on 
record for at least one household member.
AHRI is a member of the South African Population Research 
Infrastructure Network (SAPRIN), an initiative funded by the 
National Department of Science and Innovation (DSI) and hosted 
by the South African Medical Research Council30. SAPRIN 
standardised the health and demographic surveillance proto-
cols of the three established HDSS sites, in rural KwaZulu-Natal 
(AHRI), Limpopo and Mpumalanga27,30–32. Through SAPRIN, 
the three HDSS sites agreed on a common Covid-19 surveil-
lance protocol, which each node then adapted to its specific 
local health priorities and linkage to care pathways.
Underlying HDSS
Since 2000 AHRI has conducted surveillance of approximately 
20,000 households (totalling over 100,000 resident individuals) 
to capture births, deaths, migrations and household socio-
demographics. All households under surveillance are contacted 
once during each 15-week (triannual) surveillance cycle. All 
visits were initially face-to-face, but since 2017, two of the 
three data collection encounters each year have been collected 
using a telephonic interviewing platform, which allows for 
high-throughput surveillance. These interviews are conducted 
with one household senior representative, acting as proxy for all 
other members. In addition, residents aged 15 years and older 
are invited to participate individually in an annual biobehav-
ioural survey. AHRI has also embedded data collection clerks 
within the eleven public health clinics and one district hospital 
serving the study population. These clerks electronically 
capture clinic visits and hospital admissions, and link these 
with the surveillance platform data for all consenting attendees. 
The population database is also routinely linked to the elec-
tronic tuberculosis and HIV treatment registers at these facilities. 
AHRI holds memoranda of understanding with the Provincial 
and District DoH that permit extraction of health record 
data from primary care and hospital sites for linkage to the 
household surveillance dataset.
Study design
The overall flow of this study is described in Figure 1.
Household questionnaires
This protocol builds upon the underlying routine health and 
demographic surveillance. For the duration of the Covid-19 
lockdown period (and until it is deemed safe by both the South 
African government and study investigators), physical household 
visits have been suspended and replaced by telephonic 
interviews with the household proxy respondent. In addition to the 
standard demographic surveillance questions, proxy respondents 
are asked to answer a Covid-19 questionnaire covering:
a.    A screen for symptoms of Covid-19 for each resident 
household member, completed either by the proxy 
informant or the household member, if available;
b.    Epidemiologic risk factors for Covid-19 including 
known contacts, healthcare contact, and travel;
c.    Household awareness of Covid-19;
d.    Behaviour changes in response to the epidemic;
e.    Recent visitors to the household and recent travel 
patterns;
f.    Economic and healthcare impacts of Covid-19 non-
pharmaceutical interventions on the household;
g.    Brief mental health assessments of the household 
respondent, using the Patient Health Questionnaire-2 
and Generalized Anxiety Disorder-2 screening tools33,34;
The Covid-19 questionnaire takes about 15-20 minutes to 
administer telephonically, whereas when it is integrated into the 
household demographic surveillance questionnaire, the complete 
questionnaire takes about 45 minutes in total.
To improve the temporal resolution of Covid-19 surveillance, 
a cohort of 750 households (approximately 3,750 individuals) 
will also be invited to participate in more intensive surveillance, 
with calls every two weeks, during which all Covid-19 
questions are repeated. The intensive household cohort were 
randomly selected from all households for which at least one 
member also participated in a recent population-wide HIV, 
tuberculosis, and non-communicable disease healthcare screening 
study.
Individual questionnaires
To ensure that detailed information on reaction to the Covid-19 
pandemic is available on the full age-range of residents, we 
will sample 400 past participants in the healthcare screening 
study, stratifying by age and gender, and oversampling those 
with multiple non-communicable health conditions. These indi-
viduals will be invited to participate in two-weekly calls to 
report directly on how the epidemic has affected them, includ-
ing detailed descriptions of their travel and direct personal 
contact with others.
Additionally, planned qualitative work will gather in-depth 
information from a further sub-sample of the study popula-
tion using telephone interviews to adhere with national social 
distancing regulations. This will allow an in-depth understand-
ing of perceptions of risks associated with Covid-19, and vulner-
abilities experienced by the community. Data collection tools for 
this have been informed by risk perceptions contributory 
domains including knowledge, personal risk, severity and prob-
ability of possible outcomes, response efficacy as well as 
precautionary behaviour and use of information sources. 
Aspects of vulnerability within the tool focus on how likely the 
respondent thought he or she was to get the disease and aspects 
they thought made someone vulnerable to COVID-19. Working 
with local traditional leaders will help identify contextually 
appropriate solutions to deleterious effects of both Covid-19 
epidemic and non-pharmaceutical interventions used to mitigate its 
effects.
Clinical screening of persons under investigation
If a household member screens positive as a potential person 
under investigation (PUI) for Covid-19, based on the current 
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Figure 1. Study flow diagram.
South African Covid-19 screening guidelines (see full 
screening algorithm in Supplementary Material35), the individual 
is referred to an AHRI Covid-19 mobile testing centre for 
screening and a possible diagnostic test. These mobile testing 
centres will come to within walking distance of participant 
homes. The testing centres are staffed by AHRI research 
assistants and senior professional nurses and include strict 
infection control and personal protective equipment procedures35. 
A research assistant performs a symptom and epidemiologic 
screen to confirm PUI status. Those meeting PUI criteria 
are referred to a professional nurse who conducts a clinical 
examination for triage, including temperature, respiratory rate, and 
oxygensaturation monitoring. Nurses then complete a testing and 
referral questionnaire (see Supplementary Material35) on a tablet 
computer using web-based REDCap forms36. Responses trigger 
assignment to one of the following statuses:
a. PUIs who meet the case definition, and require 
clinical care will undergo Covid-19 testing and 
specimen collection, and then be referred to a local 
Covid-19 treatment facility;
b. PUIs who meet the case definition, but who do not 
require clinical care, will undergo Covid-19 testing 
and specimen collection, and then be referred home for 
self-isolation after being given self-isolation and general 
Covid-19 educational materials;
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c. Individuals who do not meet the case definition for 
testing and require clinical care will be referred to a 
local health care facility;
d. Individuals who do not meet the case definition and 
do not require clinical care will be sent home with 
Covid-19 information material.
Specimen collection and testing
Specimen collection consists of nasopharyngeal swab and 
oropharyngeal swabs placed together into a cryovial containing 
2 ml viral transport medium labelled with a unique DataMatrix37 
barcode and electronically logged. For young children a single 
nasal mid-turbinate swab (collected from both nostrils) will 
replace the nasopharyngeal and oropharyngeal swabs. Specimens 
will be stored and shipped at 2–8°C to the AHRI Diagnostic 
Laboratory in Durban within 24 hours of sample collection, for 
processing and testing.
On receipt in the AHRI Diagnostic Laboratory, the specimens 
will be registered and tracked on the Laboratory Information 
Management system (LIMS)38 and undergo inactivation (at 60°C 
for 30 minutes). Following inactivation, extraction will be per-
formed either manually using the QIAamp® Viral RNA kit 
(Qiagen, Germany) or on the ChemagicTM 360 Nucleic Acid 
Extractor (Perkin Elmer, Waltham, MA, USA) using ChemagicTM 
Viral DNA/RNA 300 Kit H96 (Perkin Elmer, Waltham, MA, 
USA). SARS-CoV-2 templates will be generated using the 
TaqManTM 2019-nCoV Assay Kit v1 or v2 (Applied Biosystems, 
Foster City, CA, USA) and run on The Applied Biosystems 
QuantStudio 5 or 7 Real-Time PCR System by the KwaZulu- 
Natal Research Innovation and Sequencing Platform (KRISP) 
or by AHRI on a CFXTM Touch Real-Time System (Bio-Rad 
(Hercules, CA, USA) or Abbott m2000rt).
We will use comparative Ct to analyse 2019-nCoV assay 
data, with Ct <37 regarded as positive (CoV-2 RNA detected), 
Ct ≥37 but <40 considered indeterminate, and Ct ≥40 as negative. 
Indeterminate results will be repeated from the amplifica-
tion process and if found to be indeterminate, the sample 
re-extracted and amplified; if the sample remains indeterminate 
it will be reported as suspected positive/positive. Positive cases 
with a Ct <20 will be genotyped using the ARTIC network 
SARS-CoV-2 whole genome sequencing (WGS) protocol at 
KRISP39. WGS will be assembled using Genome Detective40 
and analysed using phylogenetic software applications, such as 
BEAST41 and Nextstrain42. All genomes will be analysed with 
over 12,000 WGS publicly available in the GISAID database43.
Results reporting and disease monitoring
The SARS-CoV-2 test results will be electronically transferred 
to the study database and presented for clinical review to the 
study physician.
a. PUIs testing negative for SARS-CoV-2 will be informed 
of their results via short message service (SMS);
b. PUIs testing positive for SARS-CoV-2 will be called 
by a study physician to be informed of their results. 
Covid-19 cases will be followed longitudinally with 
phone calls every three days for clinical monitoring 
until resolution of symptoms. Those with worsening 
symptoms will be referred to the AHRI mobile testing 
centre for further attention and, if warranted, referral to 
the regional Covid-19 treatment centre.
All Covid-19 test results will be submitted to the national notifiable 
medical conditions web portal; a system-generated PUI 
(including a contacts list) form will also be submitted to the 
local public health service.
After the Covid-19 outbreak and upon resumption of the par-
ent AHRI surveillance protocol, which provides for an annual 
dried blood spot collection from resident individuals age 15 
years and above, the protocol provides for measurement of 
SARS-CoV-2 seroprevalence, which will be conducted to deter-
mine contributions of asymptomatic disease to the epidemic.
All participants with positive COVID-19 test results will be 
considered for enrolment in a related study titled, “Consequences 
of HIV and TB Co-Infection on COVID-19 Disease Dynamics, 
Severity and Immune Responses,” which is a longitudinal dis-
ease characterization and sample collection protocol to establish 
mechanistic interactions between HIV, TB and COVID-19.
Data analysis and sample size
We will collect and report Covid-19 surveillance data in 
real-time to local partners, including the DoH and the AHRI 
Community Advisory Board. At the conclusion of each week, 
we will report the following indicators to key stakeholders:
1. Number of households screened by phone call;
2. Number of individuals screened (through proxy);
3. Proportion of households contacted and consented;
4. Proportion of households and individuals with a 
positive case definition screen;
5. Number of PUI screened at Covid-19 clinics;
6. Number of Covid-19 tests conducted;
7. Number and proportion of Covid-19 tests resulting 
positive;
8. Number of individuals referred to clinic for moderate/
severe Covid-19 disease;
9. Population-representative prevalence of Covid-19 
overall and by age and sex.
At the conclusion of each 15-week surveillance block, we will 
additionally conduct a total population Covid-19 epidemio-
logic summary, including age, sex, and HIV-serostatus stratified 
Covid-19 prevalence and prevalence of moderate/severe disease. 
This project is designed to conduct surveillance of the entire 
HDSS population area and thus is not powered to test a specific 
hypothesis. However, with a total population sample size of 
100,000, and assuming 60% participation in each 15-week block 
from at least one household member, we will have substantial 
power to estimate overall and stratified Covid-19 prevalence 
estimates within age and sex strata (Table 1).
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The data collected will provide the opportunity to conduct a 
wide range of analyses. In particular, the 750-household cohort 
will allow local epidemic dynamics to be carefully mapped to 
changes in behaviour, individual wellbeing and household 
economic and healthcare access, using methods including 
time-to-event and interrupted time series analysis. Existing 
data, both collected by AHRI and routinely collected by others 
and linked to AHRI unique identifiers, will allow comparison of 
residents’ current situation with that in previous years.
Data management. Data collected in this study will be centrally 
stored on AHRI’s secure data servers. Data will be collected 
through interviews at the call centre on central server using Sur-
vey Solutions44, and in the field on encrypted tablet computers 
using REDCap, and then securely uploaded to a central server. 
Collected specimens will be logged on CRF system and control 
lists generated to verify that all specimens have arrived at the 
laboratory. These lists will be electronically transferred to LIMS. 
An electronic study dashboard will assist operational teams in 
monitoring study progress. Database rules and constraints will be 
enforced on the master database to ensure that only valid data is 
stored. Personally identifiable data will be restricted to separate 
database tables accessible only to data management staff – these 
will never be shared with the research team.
Risks and benefits for participants
The protocol adheres to the provisions of the Covid-19-specific 
National Infection Prevention and Control Strategic Framework45, 
as well as research conduct guidance by national and interna-
tional research oversight bodies. The main risk to study activi-
ties and participation is of SARS-CoV-2 transmission from 
in-person interactions between staff and study participants 
(i.e., at testing centres). Following a risk assessment35, we have 
implemented multiple control measures to minimize this risk, 
including: physical barriers; physical distancing; regular hand 
hygiene; and careful training on and use of standard operating 
procedures. Should it become impossible to comply with 
these provisions due to personal protective equipment supply 
shortages, case load, or other unforeseen challenges, surveillance 
will be paused, scaled back or terminated.
Consent and assent
This protocol builds on the consent procedures in place for the 
household surveillance protocol it is embedded in. All households 
contacted for this study have previously provided written 
consent to: (i) be approached via a telephone call to be asked 
to participate in research studies; (ii) electronic linkage of 
surveillance study records with their medical records; and (iii) the 
sharing of anonymized data in data repositories accessible 
to the broader scientific community.
In this study, all participants are asked to provide verbal 
informed consent35 prior to telephone interviews, which will be 
recorded in accordance with Covid-19 specific guidance from 
the University of KwaZulu-Natal Biomedical Research Ethics 
Committee46. Additionally, verbal consent for specimen 
collection and testing will be obtained (and recorded on the 
electronic case form) at the specimen collection point. Verbal 
recording of consent will remove the danger of transmitting 
SARS-COV-2 via the data collection tablet or a stylus. Any 
potential participants aged under 18 and not emancipated will 
be asked to provide recorded verbal assent after a responsible 
adult has provided informed consent.
Community engagement
The protocol was presented to both the DoH and the AHRI 
Community Advisory Board management committee and 
approved by both prior to submission for ethical approval. Bulk 
SMS messages are used to communicate Covid-19 information 
and study specific arrangements to the research population. 
Local radio stations will broadcast information on the study 
and feature interviews with study staff.
Table 1. The 95% confidence intervals for prevalence estimates for surveillance platform based on sub-group 
and total population prevalence of 1 and 5%.
Sex Age Band Population Size 95% confidence interval for 1% prevalence*
95% confidence interval for 5% 
prevalence*
Female <19 years 21,922 0.87 – 1.11% 4.71 – 5.29%
Male <19 years 22,041 0.87 – 1.13% 4.71 – 5.30%
Female 20–49 
years
23,853 0.87 – 1.13% 4.73 – 5.29%
Male 20–49 
years
17,220 0.86 – 1.16% 4.67 – 5.33%
Female >49 years 11,241 0.82 – 1.20% 4.60 – 5.42%
Male >49 years 4,958 0.75 – 1.33% 4.41 – 5.64%
Total Pop -- 101,235 0.94 – 1.06% 4.87 – 5.13%
*Confidence intervals estimated with the exact method to account for small proportion sizes.
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Ethical approval
The protocol received ethical approval from the University of 
KwaZulu-Natal Biomedical Research Ethics Committee on 
2 April 2020 under reference BE290/16 and from the KwaZulu 
DoH Research Committee.
Dissemination policy
The key findings of this study will be prepared for dissemination 
as rapidly as possible, given the urgency of the Covid-19 
epidemic. These will be provided to the DSI and other 
government decision-makers at national and provincial levels, 
including the provincial DoH. They will also be submitted to 
open-access pre-print servers and as open-access articles to 
peer-reviewed journals.
Study limitations
One limitation is the possibility of not re-interviewing the partici-
pant in the next round. On average, 12.0% (range 5.7%–16.9%) 
of HDSS participants are not re-interviewed the next year due 
to out migration, death, loss to follow-up or refusal. Over 80% 
of these losses are due to outmigration; however, 80% of these 
outmigrants remain household members, and are therefore 
accessible to collect outcome data. Additionally, for an acute 
infection with a relatively short symptom duration, the 15 weeks 
between surveillance contacts means that some proportion 
of cases will be missed. This limitation is mitigated to some 
extent by the two-weekly surveillance of 750 households, but 
the analytical power of this cohort will depend on the cumu-
lative incidence of Covid-19 in the overall study population. 
Moreover, our study depends on symptomatic screening and 
proxy responses by heads of households, which will also be 
susceptible to under-reporting47–49. Proxy-based case identifica-
tion will be augmented by documentation of cases from the study 
community presenting at the eleven primary health care clinics 
and one district hospital in the population study catchment area. 
Our ability to conduct a post-outbreak seroprevalence study 
will allow for detection of missed cases in this surveillance 
program, and ultimately serve a complementary role in epidemic 
description in this population.
Discussion
Widespread SARS-CoV-2 testing for surveillance and case 
identification has been established as a major priority in the 
epidemic response. Although testing capacity has been limited 
in many areas of the world, HDSS provide a pre-existing 
structure in resource-limited settings that is purpose-built for 
surveillance, with both expertise and infrastructure for conducting 
population-based surveys.
We have leveraged a HDSS to develop and implement a Covid-19 
surveillance program in rural South Africa. In doing so, we 
focused on the following major considerations to ensure both 
optimal scientific methods and the safety of our staff and 
study population:
1. Total-population sampling, with enhanced surveillance 
of random sub-samples for early identification of high 
transmission areas and groups;
2. Phone-based screening surveillance to minimize 
in-person contact;
3. Limiting all in-person interactions to persons under 
investigation;
4. Strict adherence to personal protective equipment 
use, well-trained staff using standardized operating 
procedures and risk mitigation plans, and hygiene 
measures in line with national and international 
guidelines;
5. Laboratory procedure conducted in a clinical research 
laboratory within good laboratory clinical practice 
guidelines;
6. Partnership with DoH and other government 
departments for case detection, reporting, contact tracing 
and to ensure all procedures fall within governmental 
guidance;
7. Real-time reporting of surveillance results to inform 
epidemic response and resource allocation.
8. Leveraging routinely collected data such as household 
socio-economic status, individual employment and 
education status and linkage to individual health 
service data to determine the impact of the Covid-19 
pandemic on household socio-economic status and 
health care delivery.
Herein we report the details of our cohort design, questionnaires, 
data and reporting structures, and standard operating 
procedures in hopes that our project can be used to hel inform 
other similar programs elsewhere in the region.
Future data availability
A core set of the Covid-19 surveillance indicators and data will 
made available for the three SAPRIN nodes in the publicly 
accessible SAPRIN data repository (http://saprindata.samrc.
ac.za/index.php/catalog). AHRI-specific data will be disseminated 
through the AHRI data repository (https://data.africacentre.
ac.za/) within six months from the conclusion of the first 15-week 
surveillance cycle. Both datasets will be linkable to existing core 
demographic surveillance data.
Data availability
Underlying data
No underlying data are associated with this article.
Extended data
Zenodo: Protocol: Leveraging a demographic and health 
surveillance system for Covid-19 Surveillance in rural 
KwaZulu-Natal Supplementary Material. https://doi.org/10.5281/
zenodo.399252735
This project contains the following extended data:
• Suppl Mat 1.docx (South African national Covid-19 
screening algorithm)
• Suppl Mat 2.docx (Standard Operating Procedures)
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• Suppl Mat 3.docx (Questionnaires)
• Suppl Mat 4.docx (Risk Assessment)
• Suppl Mat 5.docx (Informed consent wording)
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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